- Jorey Chernett, a 10% owner of Oncology Institute, reported a purchase of 50,000 common shares.
- The shares were acquired at a weighted average price of USD 3.15 per share.
- Following the reported transaction, Chernett beneficially owned 10,451,929 common shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000921895-26-000814), on March 27, 2026, and is solely responsible for the information contained therein.
Comments